Jiangsu Hengrui Pharmaceuticals Co.,Ltd
Research Jiangsu Hengrui Pharmaceuticals Co.,Ltd (0BO) on Bullrun: market cap EUR 34.85B, P/E 35.0, dividend yield 0.5%. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- Ticker0BO
- ExchangeF
- CountryChina
- SectorHealthcare
- IndustryDrug Manufacturers - Specialty & Generic
- CurrencyEUR
- Market capEUR 34.85B
- P/E35.0
- Dividend yield0.5%
- Financial periodQ1 2026
- RevenueCNY 8.14B
- Net incomeCNY 2.28B
- Free cash flowCNY 81.63M
- Gross margin86.6%
Valuation Snapshot
latest market cap is EUR 34.85B; P/E is 35.0; dividend yield is 0.5%.
Peer valuation comparison
Latest P/E is 35x versus a Healthcare sector median of 24.46x (43.1% above).
Latest dividend yield is 0.49% versus a Healthcare sector median of 2.11% (76.8% below).
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-27 | EUR 34.85B | 35.0 | 0.4% | 0.03 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0.03 EUR, yield 0.5%.
About Jiangsu Hengrui Pharmaceuticals Co.,Ltd
Jiangsu Hengrui Pharmaceuticals Co.,Ltd, a pharmaceutical company, researches, develops, manufactures, and commercializes medicines to address unmet clinical needs in China and internationally. The company develops medicines in the areas of oncology, metabolic and cardiovascular, immunological and respiratory, neuroscience, pain management, infectious, respiratory system, hematological, ophthalmology, and autoimmune and other diseases. The company was founded in 1970 and is headquartered in Lianyungang, China.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Jiangsu Hengrui Pharmaceuticals Co.,Ltd's market cap?
Jiangsu Hengrui Pharmaceuticals Co.,Ltd's market capitalization is EUR 34.85B.
What is Jiangsu Hengrui Pharmaceuticals Co.,Ltd's P/E ratio?
Jiangsu Hengrui Pharmaceuticals Co.,Ltd's price-to-earnings (P/E) ratio is 35.0.
Does Jiangsu Hengrui Pharmaceuticals Co.,Ltd pay a dividend?
Jiangsu Hengrui Pharmaceuticals Co.,Ltd has a dividend yield of 0.5%.
What does Jiangsu Hengrui Pharmaceuticals Co.,Ltd do?
Jiangsu Hengrui Pharmaceuticals Co.,Ltd, a pharmaceutical company, researches, develops, manufactures, and commercializes medicines to address unmet clinical needs in China and internationally. The company develops medicines in the areas of oncology, metabolic and cardiovascular, immunological and respiratory, neuroscience, pain management, infectious, respiratory system, hematological, ophthalmology, and autoimmune and other diseases. The company was founded in 1970 and is headquartered in Lianyungang, China.